Discriminative stimulus effects of (-)-ephedrine in rats: Analysis with catecholamine transporter and receptor ligands

Drug and Alcohol Dependence

Volumn 70, Issue 3, 2003, Pages 255-264

  McMahon, Lance R ^a,b   Cunningham, Kathryn A ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Dopamine; Drug discrimination; Ephedrine; Ma Huang; Norepinephrine; Rat

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; APOMORPHINE; CATECHOLAMINE RECEPTOR; CLONIDINE; DESIPRAMINE; EPHEDRINE; ETICLOPRIDE; HALOPERIDOL; IDAZOXAN; MAZINDOL; NISOXETINE; NOMIFENSINE; PRAZOSIN; PROPRANOLOL; QUINPIROLE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; DISCRIMINATIVE STIMULUS; DRUG BINDING; DRUG EFFECT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EPHEDRA;

EID: 0038325707     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(03)00011-5     Document Type: Article

References (51)

1. Anderson K.G., Winger G., Woods J., Woolverton W.L. Reinforcing and discriminative-stimulus effects of ephedrine isomers in rhesus monkeys. Drug Alcohol Depend. 65:2001;45-53.
2. Angrist B., Rotrosen J., Kleinberg D., Merriam V., Gershon S. Dopaminergic agonist properties of ephedrine - theoretical implications. Psychopharmacology. 55:1977;115-120.
3. Arch J.R.S., Ainsworth A.T., Cawthorne M.A. Thermogenic and anorectic effects of ephedrine and congeners in mice and rats. Life Sci. 30:1982;1817-1826.
4. Bowyer J.F., Newport G.D., Slikker W., Gough B., Ferguson S.A., Tor-Agbidye T. An evaluation of l-ephedrine neurotoxicity with respect to hyperthermia and caudate/putamen microdialysate levels of ephedrine, dopamine, serotonin, and glutamate. Toxicol. Sci. 55:2000;133-142.
5. Briscoe R.J., Vanecek S.A., Vallett M., Baird T.J., Holloway F.A., Gauvin D.V. Reinforcing effects of caffeine, ephedrine, and their binary combinations in rats. Pharmacol. Biochem. Behav. 60:1998;685-693.
6. Brown E.R., Jarvie D.R., Simpson D. Use of drugs at raves. Scott. Med. J. 40:1995;168-171.
7. 2 mediation of the discriminative stimulus properties of d-amphetamine and cocaine. Psychopharmacology. 103:1991;50-55.
8. Chait L.D. Factors influencing the reinforcing and subjective effects of ephedrine in humans. Psychopharmacology. 113:1994;381-387.
9. Chen K.K., Schmidt C.F. Ephedrine and related substances. Medicine. 9:1930;1-117.
10. Cunningham K.A., Callahan P.M. Monoamine reuptake inhibitors enhance the discriminative state induced by cocaine in the rat. Psychopharmacology. 104:1991;177-180.
11. Food and Drug Administration 1997. Dietary supplements containing ephedrine alkaloids. Fed. Register 62, 30677-30724.
12. Gauvin D.V., Moore K.R., Youngblood B.D., Holloway F.A. The discriminative stimulus properties of legal, over-the-counter stimulants administered singly and in binary and ternary combinations. Psychopharmacology. 110:1993;309-319.
13. Glennon R.A., Young R. (+)-Amphetamine-stimulus generalization to an herbal ephedrine product. Pharmacol. Biochem. Behav. 65:2000;655-658.
14. Gold L.H., Balster R.L. Evaluation of the cocaine-like discriminative stimulus effects and reinforcing effects of modafinil. Psychopharmacology. 126:1996;286-292.
15. Grenhoff J., Svennson T.H. Clonidine modulates dopamine cell firing in the rat ventral tegmental area. Eur. J. Pharmacol. 165:1989;11-18.
16. Holloway F.A., Michaelis R.C., Huerta P.L. Caffeine-phenylethylamine combinations mimic the amphetamine discriminative cue. Life Sci. 36:1985;723-730.
17. Johanson C.-E., Barrett J.E. The discriminative stimulus effects of cocaine in pigeons. J. Pharmacol. Exp. Ther. 267:1993;1-8.
18. Kamien J.B., Woolverton W.L. A pharmacological analysis of the discriminative stimulus properties of d-amphetamine in rhesus monkeys. J. Pharmacol. Exp. Ther. 248:1989;938-947.
19. Katz J.L., Izenwasser S., Terry P. Relationships among dopamine transporter affinities and cocaine-like discriminative-stimulus effects. Psychopharmacology. 148:2000;90-98.
20. Kleven M.S., Anthony E.W., Woolverton W.L. Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys. J. Pharmacol. Exp. Ther. 254:1990;312-317.
21. Kleven M.S., Koek W. Discriminative stimulus properties of cocaine: enhancement by beta-adrenergic receptor antagonists. Psychopharmacology. 131:1997;307-312.
22. Kleven M.S., Koek W. Discriminative stimulus properties of cocaine: enhancement by monoamine reuptake blockers. J. Pharmacol. Exp. Ther. 284:1998;1015-1025.
23. Koe B.K. Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J. Pharmacol. Exp. Ther. 199:1976;649-661.
24. Malec D., Langwinski R., Kruszewska A. The role of serotonin in ephedrine-induced stereotypy and hypermotility. Arch. Immunol. Ther. Exp. 24:1976;829-836.
25. Martin W.R., Sloan J.W., Sapira J.D., Jasinski D.R. Physiological, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine and methylphenidate in man. Clin. Pharmacol. Ther. 12:1971;245-258.
26. 2A receptors attenuates the behavioral effects of cocaine in rats. J. Pharmacol. Exp. Ther. 297:2001;357-363.
27. McMahon L.R., Jones S.L., Gilliland T.R., Hall W.D., Wellman P.J. Effects of ephedrine enantiomers on conditioned taste aversion and kaolin intake in rats. Pharmacol. Biochem. Behav. 63:1999;119-124.
28. Miller D.K., McMahon L.R., Green T.A., Nation J.R., Wellman P.J. Repeated administration of ephedrine induces behavioral sensitization in rats. Psychopharmacology. 140:1998;52-56.
29. Miller D.K., Nation J.R., Wellman P.J. Sensitization of anorexia and locomotion induced by chronic administration of ephedrine in rats. Life Sci. 65:1999;501-511.
30. Munzar P., Goldberg S.R. Noradrenergic modulation of the discriminative-stimulus effects of methamphetamine in rats. Psychopharmacology. 143:1999;293-301.
31. National Institute on Drug Abuse, 1999. International Epidemiology Work Group on Drug Abuse. National Institutes of Health, Washington DC, Proceedings June 1999.
32. Nielsen E.B., Scheel-Kruger J. Central nervous system stimulants: neuropharmacological mechanisms. Psychopharmacol. Ser. 4:1988;57-72.
33. Robinson T., Berridge K. The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Res. Rev. 18:1993;247-291.
34. Rothman R.B., Baumann M.H., Dersch C.M., Romero D.V., Rice K.C., Carroll F.I., Partilla J.S. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse. 39:2001;32-41.
35. Schechter M.D., Boja J.W. Lack of generalization of nisoxetine with amphetamine in the rat. Pharmacol. Biochem. Behav. 30:1988;1085-1088.
36. Schulte J.W., Reif E.C., Bacher J.A., Lawrence W.S., Tainter M.L. Further study of central stimulation from sympathomimetic amines. J. Pharmacol. Exp. Ther. 71:1941;62-74.
37. Shannon H.E., DeGregorio C.M. Self-administration of the endogenous trace amines β-phenylethylamine, N-methyl phenylethylamine and phenylethanolamine in dogs. J. Pharmacol. Exp. Ther. 222:1982;52-60.
38. Snoddy A.M., Tessel R.E. Nisoxetine and amphetamine share discriminative stimulus properties in mice. Pharmacol. Biochem. Behav. 19:1983;205-210.
39. Snoddy A.M., Tessel R.E. Prazosin: effect on psychomotor-stimulant cues and locomotor activity in mice. Eur. J. Pharmacol. 116:1985;221-228.
40. Spealman R.D. Noradrenergic involvement in the discriminative stimulus effects of cocaine in squirrel monkeys. J. Pharmacol. Exp. Ther. 275:1995;53-62.
41. 2 dopamine receptors in the behavioral effects of cocaine. Neurochem. Int. 20:1992;147S-152S.
42. Tallarida R.J., Murray R.B. Manual of Pharmacological Calculations with Computer Programs. 1987;Springer, New York.
43. Tancer M.E., Johanson C.E. The subjective effects of MDMA and mCPP in moderate MDMA users. Drug Alcohol Depend. 65:2001;97-101.
44. Terry P., Witkin J.M., Katz J.L. Pharmacological characterization of the novel discriminative stimulus effects of a low dose of cocaine. J. Pharmacol. Exp. Ther. 270:1994;1041-1048.
45. Vree T.B., Muskens A.T., Van Rossum J.M. Some physicochemical properties of amphetamine and related drugs. J. Pharm. Pharmacol. 21:1969;774-775.
46. Wellman P.J., Miller D.K., Livermore C.L., Green T.A., McMahon L.R., Nation J.R. Effects of (-)-ephedrine on locomotion, feeding, and nucleus accumbens dopamine in rats. Psychopharmacology. 135:1998;133-140.
47. Wise R.A., Rompre P.P. Brain dopamine and reward. Ann. Rev. Psychol. 40:1989;191-225.
48. Yates K.M., O'Connor A., Horsley C.A. 'Herbal Ecstasy': a case series of adverse reactions. N.Z. Med. J. 113:2000;315-317.
49. Young R., Gabryszuk M., Glennon R.A. Ephedrine and caffeine mutually potentiate one another's amphetamine-like stimulus effects. Pharmacol. Biochem. Behav. 61:1998;169-173.
50. Young R., Glennon R.A. Discriminative stimulus properties of (-)ephedrine. Pharmacol. Biochem. Behav. 60:1998;771-775.
51. Zarrindast M.R. Dopamine-like properties of ephedrine in rat brain. Br. J. Pharmacol. 74:1981;119-122.